Artia Global Partners LP Kura Oncology, Inc. Transaction History
Artia Global Partners LP
- $517 Billion
- Q2 2024
A detailed history of Artia Global Partners LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 57,178 shares of KURA stock, worth $956,016. This represents 0.23% of its overall portfolio holdings.
Number of Shares
57,178
Previous 39,478
44.84%
Holding current value
$956,016
Previous $842 Million
39.81%
% of portfolio
0.23%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding KURA
# of Institutions
180Shares Held
79.5MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$118 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$116 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$97.1 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$90.5 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$75.9 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.12B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...